|
the paper you quoted discusses Local recurrence only and fortunately
it looks like being her2+ does not make local recurrence more likely (than if tumor was her2-) when treated with lumpectomy with radiation therapy.
If only the rates of distal metastasis were equally low!
As part of my review regarding whether the risks outweighed the benefits of radiating an 84 year old patient with a her2+ breast cancer I came upon the only article discussing the rate of local recurrence (and distal metastasis/overall survival)in elderly her2+ patients treated with BCT with radiation therapy.
I thought others might benefit from it--including Tom:
|
Threaded Mode